We have located links that may give you full text access.
Synthesis and basic evaluation of 7α-(3-[(18)F]fluoropropyl)-testosterone and 7α-(3-[(18)F]fluoropropyl)-dihydrotestosterone.
Annals of Nuclear Medicine 2017 January
OBJECTIVE: 7α-Substituted androgen derivatives may have the potential to visualize androgen receptors with positron emission tomography. In the present study, we synthesized fluoropropyl derivatives of 7α-(3-[(18)F]fluoropropyl)-testosterone ([(18)F]7) and 7α-(3-[(18)F]fluoropropyl)-dihydrotestosterone ([(18)F]15), and characterized their in vitro binding, in vivo biodistribution, and performed blocking studies in mature androgen deprived male rats.
METHODS: We synthesized [(18)F]7 and [(18)F]15. In vitro binding to recombinant rat AR ligand binding domain protein was determined using a competitive radiometric ligand-binding assay with the high-affinity synthetic androgen [17α-methyl-(3)H]-methyltrienolone ([(3)H]R1881). In vivo biodistribution was performed in mature male rats treated with diethylstilbestrol (chemical castration). A blocking study was performed by co-administration of dihydrotestosterone (36 µg/animal).
RESULTS: 7α-(3-Fluoropropyl)-testosterone (7) and 7α-(3-fluoropropyl)-dihydrotestosterone (15) showed competitive binding to recombinant rat AR ligand binding domain protein. The IC50 value of 15 (13.0 ± 3.3 nM) was higher than 7 (47.8 ± 10.0 nM). In contrast to the AR binding affinity, the ventral prostate uptake of [(18)F]7 and [(18)F]15 at 2 h post-injection was similar (0.07 % injected dose/g of tissue). A blocking study indicated that specific binding of [(18)F]15 is observed in the ventral prostate. [(18)F]7 and [(18)F]15 showed moderate levels of bone uptake, which indicates moderate metabolic de-fluorination in rodents.
CONCLUSION: [(18)F]15 is better than [(18)F]7 in terms of radiochemical yield, in vitro binding affinity, prostate specific binding and stability against in vivo metabolic de-fluorination. However, the net uptake level of [(18)F]15 in prostate might be insufficient for in vivo visualization. Although [(18)F]7 and [(18)F]15 improved in vivo stability against de-fluorination, other basic characterization data in rodents were not superior to the current standard tracer 16β-[(18)F]fluoro-5α-dihydrotestosterone. It is also revealed that the shorter side chain length of 7α-[(18)F]fluoromethyl-dihydrotestosterone is superior to the longer three carbon chain in [(18)F]15, in terms of net prostate uptake and in vivo metabolic stability.
METHODS: We synthesized [(18)F]7 and [(18)F]15. In vitro binding to recombinant rat AR ligand binding domain protein was determined using a competitive radiometric ligand-binding assay with the high-affinity synthetic androgen [17α-methyl-(3)H]-methyltrienolone ([(3)H]R1881). In vivo biodistribution was performed in mature male rats treated with diethylstilbestrol (chemical castration). A blocking study was performed by co-administration of dihydrotestosterone (36 µg/animal).
RESULTS: 7α-(3-Fluoropropyl)-testosterone (7) and 7α-(3-fluoropropyl)-dihydrotestosterone (15) showed competitive binding to recombinant rat AR ligand binding domain protein. The IC50 value of 15 (13.0 ± 3.3 nM) was higher than 7 (47.8 ± 10.0 nM). In contrast to the AR binding affinity, the ventral prostate uptake of [(18)F]7 and [(18)F]15 at 2 h post-injection was similar (0.07 % injected dose/g of tissue). A blocking study indicated that specific binding of [(18)F]15 is observed in the ventral prostate. [(18)F]7 and [(18)F]15 showed moderate levels of bone uptake, which indicates moderate metabolic de-fluorination in rodents.
CONCLUSION: [(18)F]15 is better than [(18)F]7 in terms of radiochemical yield, in vitro binding affinity, prostate specific binding and stability against in vivo metabolic de-fluorination. However, the net uptake level of [(18)F]15 in prostate might be insufficient for in vivo visualization. Although [(18)F]7 and [(18)F]15 improved in vivo stability against de-fluorination, other basic characterization data in rodents were not superior to the current standard tracer 16β-[(18)F]fluoro-5α-dihydrotestosterone. It is also revealed that the shorter side chain length of 7α-[(18)F]fluoromethyl-dihydrotestosterone is superior to the longer three carbon chain in [(18)F]15, in terms of net prostate uptake and in vivo metabolic stability.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app